Last reviewed · How we verify

NCT06569719

Effectiveness of CDT for the Treatment of Lymphedema in Breast Cancer Patients Who Received LVA Surgery

Completed NA Last updated 17 January 2025
What this trial tests

NA trial testing Complex decongestive therapy in Breast Cancer Lymphedema in 10 participants. Completed in 30 December 2024.

Timeline
1 February 2024
Primary endpoint
14 August 2024
30 December 2024

Quick facts

Lead sponsorFundacion Universitaria Maria Cano
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment10
Start date1 February 2024
Primary completion14 August 2024
Estimated completion30 December 2024
Sites2 locations across Colombia

Drugs / interventions tested

Conditions studied

Sponsor

Fundacion Universitaria Maria Cano

Who can join

Adults 18 to 85, any sex, with Breast Cancer Lymphedema. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Breast cancer is the most common type of cancer in women worldwide. Advances in treatment have increased survival rates, so patients must live with the complications resulting from the cancer and its treatment. One of the most common side effects is lymphedema, which can occur as a secondary effect of surgical or radiotherapy treatment. Lymphatic edema is a condition characterized by an excess of lymphatic fluid, rich in proteins, in the subcutaneous tissue, causing pain, a feeling of heaviness in the affected limb, restricted range of motion, and, in some cases, progressing to the formation of ulcers and recurrent infections; inevitably affecting the quality of life of the women who suffer from it. There are various therapeutic strategies to reduce the risk of developing lymphedema or to treat it. Among the management options is complex decongestive therapy (CDT), which is a conservative treatment that includes manual lymphatic drainage (MLD), compression therapy, skin care, and lymph-reducing exercises (LRE). Surgical options include lymph node transfer and lymphovenous anastomosis; redirecting lymphatic circulation and reducing edema in the affected limb. This is why the current research is undertaken, aiming to evaluate the effectiveness of combining these two treatment approaches in terms of reducing lymphedema, the presence of cellulitis, and changes in patients' quality of life

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Complex decongestive therapy

Trials testing the same drug.

Other recruiting trials for Breast Cancer Lymphedema

Currently open trials in the same condition.

Other Fundacion Universitaria Maria Cano trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06569719.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing